Policy and Regulation · 25 September 2026 to 25 September 2026 · 1 headlines · STAT
STAT Plus: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
An FDA advisory panel endorsed Grail's blood test for cancer, concluding that its benefits outweigh its risks.